Method for producing 2,3,5-trimethyl benzoquinone by oxidation of 2,3,6-trimethylphenol
US-2016368887-A1 · Dec 22, 2016 · US
Chroman-derived anti-androgens for treatment of androgen mediated disorders
US9440942B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9440942-B2 |
| Application number | US-201414327942-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2014 |
| Priority date | Feb 27, 2003 |
| Publication date | Sep 13, 2016 |
| Grant date | Sep 13, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of providing nutraceutical benefits to a human patient comprising the step of administering to the patient a nutraceutical composition including: (a) a compound having the formula: (b) a pharmaceutically-acceptable salt of said compound; and (c) an acceptable carrier, wherein the nutraceutical benefits comprise treating an androgen-related disorder selected from the group consisting of hirsutism, acne, seborrhea, androgenic alopecia, hyperpilosity, benign prostatic hypertrophy, adenomas or neoplasias of the prostate, benign or malignant tumor cells containing the androgen receptor, osteoporosis, cachexia, endometriosis, polycystic ovary syndrome, male sexual dysfunction, female sexual dysfunction and infertility. 2. The method of claim 1 wherein said nutraceutical composition further comprises an immune boosting agent, anti-inflammatory agent, anti-oxidant agent, or a mixture thereof.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9440942B2 cover?
- Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particula…
- Who is the assignee on this patent?
- Wisconsin Alumni Res Found
- What technology area does this patent fall under?
- Primary CPC classification C07D311/72. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).